entity

pTau

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about pTau: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
0Hypotheses
1Analyses
3Outgoing
6Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Dual Proteinopathy Immunotherapy: Aβ + pTau/pα-Syn Bispecific

idea · 2414 words

Outgoing (3)

TargetRelationTypeStr
Alzheimer's Diseasebiomarker_fordisease0.95
Tau Pathogenesisinvolved_inprocess0.90
Lateral Ventricular Volumecorrelates_withphenotype0.70

Incoming (6)

SourceRelationTypeStr
33278887correlated withpaper0.90
33278887correlates withpaper0.90
BIN1associated_withgene0.85
OPTNregulatesgene0.80
GMNCassociated_withgene0.80

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

closed · Rounds: 4 · Score: 0.92 · 2026-04-16

Related Research

Hypotheses and analyses mentioning pTau in their description or question text

No additional research found